Psilocybin reporting in media (PRiMe) for the treatment of depression
Irish Journal of Psychological Medicine December 18, 2025 Gurjot Brar, T. R. Jun. Burke, Andrew Gribben et al.
Abstract Objectives: Interest in psilocybin as a treatment for depression has risen over the past decade, fuelled by promising clinical trials and a rapidly evolving regulatory landscape. Media coverage plays a critical role in shaping public perceptions, yet little is known about how psilocybin is portrayed in global anglophone online news for the treatment of depression. Methods: This study...